GLP-1 Weight-Loss Drugs: Potential Metabolic Instability Linked to Long-Term Use
A new study suggests that the long-term administration of GLP-1 receptor agonists—the class of anti-obesity medications surging in popularity...
Search results for "hormone receptor"
Taking Wegovy or Mounjaro? Seek Immediate Medical Attention if ‘These Symptoms’ Appear
As anti-obesity medications for weight loss and blood sugar control gain popularity, monitoring and managing potential side effects has become...
Resistance in the Genes: Why Popular Obesity Drugs Don’t Work for Everyone
GLP-1 receptor agonists like Wegovy and Mounjaro have fundamentally reshaped the treatment of diabetes and obesity.
Should You Eat More Meat as You Age? The Link Between Animal Protein, IGF-1, and Cancer
Insulin-like growth factor 1 (IGF-1) is a hormone that promotes the growth of every cell in the human body—from bones...
Can Wegovy and Mounjaro Reduce Cancer Risk?
Global obesity experts have proposed a large-scale, long-term follow-up study to verify whether the use of modern...
The Great Salt Debate: Science, History, and the Myth of Mineral Richness
In the 1970s, a group of university students imprisoned for protesting the Park Chung-hee regime found themselves...
Datroway Approved: New Targeted Therapy Offers Hope for Metastatic Breast Cancer
A new therapeutic horizon has arrived for patients battling metastatic breast cancer that has progressed despite...
A Ray of Hope: ‘Low Expression’ Changes the Landscape of Breast Cancer Treatment
The treatment landscape for metastatic breast cancer is undergoing a significant shift.
High Efficacy and Increased Convenience: The Three Obesity Drugs Awaiting FDA Approval
Since the World Health Organization recommended the use of obesity medications for adults last December, the market is...
"Breast Cancer Diagnosis, It's Too Early to Give Up" A Doctor's Calm Comfort
"Many breast cancer patients struggle with the process of fighting the disease. This is likely due to the thought that...